E-Book | April 20, 2021

Current Data Privacy Regulations Impacting The Life Sciences Industry

Source: Egnyte

By Alok Tayi, Ph.D.

GDPR iStock-956415084

The General Data Protection Regulation (GDPR) is a significant advancement of consumer data protection rights. The European member states agreed to a set of principles that would penalize organizations that don’t safeguard personal identifying information (PII). While it was hailed as the most consumer-friendly data protection regulation at the time of passing, many countries followed the EU’s lead and harmonized their laws to match - with some even surpassing- GDPR’s principles-based approach to data privacy.

The EU Regulation often overshadows other regional privacy regulations because it is so broad in scope, the penalties are significant, and it affects the second-largest economic area in the world. But it would be foolish to overlook the regulations in other privacy-minded nations and jurisdictions, some of which you are probably doing business in right now.

If your team or clinical trial operates in the EU, California, S Korea, Australia, or a dozen other countries, your data could be subject to strict privacy laws. Violating GDPR, PIPA, APP, or CCPA, among others, have serious consequences for your program. Learn how to mitigate risk and keep on the right side of regulators.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online